CTLA4 and lung cancer: In humans, several clinical case reports document that the combination of local irradiation and anti-CTLA-4 (iplimumab) in patients with melanoma [164], or NSCLC [165], can result in regression not only of irradiated but also of distant lesions in melanoma and lung cancer patients, also known as the abscopal effect.